- Photocure ASA press release ( OTC:PHCUF ): Q4 GAAP EPS of -NOK 0.79.
- Revenue of NOK 104.2M (+10.3% Y/Y).
- The EBIT was -NOK 23.1 million (-NOK 11.5 million) and the cash balance at the end of the third quarter 2022 was NOK 268.1 million.
- "We expect to deliver Hexvix/Cysview revenue growth of 20%+ and generate positive EBITDA excluding business development spending in 2023, given the large number of new accounts that have recently activated blue light equipment in their facility, as well as the strong pipeline for anticipated Saphira™ tower installations. We are already seeing signs of positive sales trends in our North American business in early 2023, and in Europe, German hospital ordering patterns appear to be phasing back to normalized growth."
For further details see:
Photocure ASA GAAP EPS of -NOK 0.79, revenue of NOK 104.2M